Arendash, G.; Abulaban, H.; Steen, S.; Andel, R.; Wang, Y.; Bai, Y.; Baranowski, R.; McGarity, J.; Scritsmier, L.; Lin, X.;
et al. Transcranial Electromagnetic Treatment Stops Alzheimer’s Disease Cognitive Decline over a 2½-Year Period: A Pilot Study. Medicines 2022, 9, 42.
https://doi.org/10.3390/medicines9080042
AMA Style
Arendash G, Abulaban H, Steen S, Andel R, Wang Y, Bai Y, Baranowski R, McGarity J, Scritsmier L, Lin X,
et al. Transcranial Electromagnetic Treatment Stops Alzheimer’s Disease Cognitive Decline over a 2½-Year Period: A Pilot Study. Medicines. 2022; 9(8):42.
https://doi.org/10.3390/medicines9080042
Chicago/Turabian Style
Arendash, Gary, Haitham Abulaban, Susan Steen, Ross Andel, Yanhong Wang, Yun Bai, Rob Baranowski, Jon McGarity, Lyle Scritsmier, Xiaoyang Lin,
and et al. 2022. "Transcranial Electromagnetic Treatment Stops Alzheimer’s Disease Cognitive Decline over a 2½-Year Period: A Pilot Study" Medicines 9, no. 8: 42.
https://doi.org/10.3390/medicines9080042
APA Style
Arendash, G., Abulaban, H., Steen, S., Andel, R., Wang, Y., Bai, Y., Baranowski, R., McGarity, J., Scritsmier, L., Lin, X., Shen, N., Aljassabi, A., Li, Y., & Cao, C.
(2022). Transcranial Electromagnetic Treatment Stops Alzheimer’s Disease Cognitive Decline over a 2½-Year Period: A Pilot Study. Medicines, 9(8), 42.
https://doi.org/10.3390/medicines9080042
